How much does Wegovy cost without insurance?

List price runs ~$1,350/mo at retail. NovoCare Pharmacy cash-pay direct from Novo Nordisk is $499/mo for all dose strengths. The Wegovy Savings Offer caps copay at $0-$225/mo for commercially insured patients depending on coverage status (not a flat $225 for everyone).

Does insurance cover Zepbound?

Most commercial insurance plans cover Zepbound with prior authorization for adults with BMI ≥30 (or ≥27 + a weight-related comorbidity). Medicare Part D excludes anti-obesity drugs by federal law, so Medicare patients pay cash unless they qualify for Lilly Cares.

Is Ozempic the same as Wegovy?

Same active molecule (semaglutide), different FDA indications and maximum doses. Ozempic = type 2 diabetes, max 2 mg/week. Wegovy = chronic weight management, max 2.4 mg/week. Insurance pathways are very different.

Can I still get compounded GLP-1 in 2026?

For semaglutide: no — FDA declared the shortage resolved February 21, 2025 and 503A compounding is no longer broadly permitted. For tirzepatide: shortage resolved October 2024 (re-affirmed December 2024), with a wind-down enforcement window that ended in 2025. Some clinics still market "compounded" formulations with added ingredients (B12, glycine) as personalized prescriptions; the legal status is contested.

How does Wegovy compare to Saxenda?

Both are GLP-1 agonists from Novo Nordisk. Wegovy (semaglutide, weekly) produces ~15% mean weight loss; Saxenda (liraglutide, daily) produces ~6-8%. Wegovy is also cheaper per kg-lost, more convenient, and has cardiovascular outcome data (SELECT trial). Saxenda was first approved for adolescents (2020); Wegovy followed in 2022 — both are available for ages 12-17.

Home ProvidersPush Health

Provider review

Push Health

Item: Push Health
Rating: 3.9
Author: Dr. Jane Novak

Direct-to-doctor GLP-1 access — no subscription, pay per visit + medication.

Medically reviewed by Dr. Jane Novak, MD, MPH 6 min read Fact checked Editorial integrity

Updated Jul 15, 2026

3.90/5 rating
From $75.00/mo
51 states
1 GLP-1

Medically reviewed by Dr. Jane Novak, MD, MPH on July 15, 2026

Rating breakdown

How this provider scored, per dimension

Editorial scores out of 5 — see our scoring rubric for the criteria behind each axis.

Overall: 3.9/5
Pricing: 4.5/5
Patient experience: 3.7/5
Delivery speed: 3.9/5
Customer support: 3.6/5
Billing clarity: 4.1/5

Push Health provider review — Push Health is a compounded GLP-1 provider operating in 51 U.S. states.Photo: Unsplash

From

$75/mo

Medications

1

States

51

Rating

3.9/5

~6 hr· self-reported

Visit Push Health Compare alternatives

We earn a commission if you sign up through this link. Editorial ranking is independent.

What we liked

No monthly membership — pay $75 per doctor visit, medication ordered separately
Best fit for patients who want minimal friction and self-directed titration
Works with a wide network of independent US-licensed doctors

What gave us pause

Less structured than Ro/Hims — no built-in follow-up cadence
Support is thinner than app-driven providers
Compounded-first; brand-name pathway is inconsistent

Reader reviews

Verified user experiences. Reviews are moderated before publishing — we strip personal info and reject spam.

Ready to try Push Health?

From $75.00/mo. Commission-funded, editorially independent.

Get started with Push Health

How to get started with Push Health Start a Push Health consultation

Common questions readers ask

How much does Wegovy cost without insurance?: List price runs ~$1,350/mo at retail. NovoCare Pharmacy cash-pay direct from Novo Nordisk is $499/mo for all dose strengths. The Wegovy Savings Offer caps copay at $0-$225/mo for commercially insured patients depending on coverage status (not a flat $225 for everyone).
Does insurance cover Zepbound?: Most commercial insurance plans cover Zepbound with prior authorization for adults with BMI ≥30 (or ≥27 + a weight-related comorbidity). Medicare Part D excludes anti-obesity drugs by federal law, so Medicare patients pay cash unless they qualify for Lilly Cares.
Is Ozempic the same as Wegovy?: Same active molecule (semaglutide), different FDA indications and maximum doses. Ozempic = type 2 diabetes, max 2 mg/week. Wegovy = chronic weight management, max 2.4 mg/week. Insurance pathways are very different.
Can I still get compounded GLP-1 in 2026?: For semaglutide: no — FDA declared the shortage resolved February 21, 2025 and 503A compounding is no longer broadly permitted. For tirzepatide: shortage resolved October 2024 (re-affirmed December 2024), with a wind-down enforcement window that ended in 2025. Some clinics still market "compounded" formulations with added ingredients (B12, glycine) as personalized prescriptions; the legal status is contested.
How does Wegovy compare to Saxenda?: Both are GLP-1 agonists from Novo Nordisk. Wegovy (semaglutide, weekly) produces ~15% mean weight loss; Saxenda (liraglutide, daily) produces ~6-8%. Wegovy is also cheaper per kg-lost, more convenient, and has cardiovascular outcome data (SELECT trial). Saxenda was first approved for adolescents (2020); Wegovy followed in 2022 — both are available for ages 12-17.

Was this page helpful?

No user reviews yet

Be the first to share your experience — consults, shipping, billing, support. The form below takes ~2 minutes.